cardiovascular
-
Sanofi India, Emcure Pharma announce distribution partnership for cardiovascular brands
Emcure Pharmaceuticals will exclusively distribute and promote the company’s cardiovascular (CV) range of products The Board of Directors of Sanofi…
Read More » -
IIT-Madras develops portable screening device to assess risk of cardiovascular diseases
The device called Artsens can be used in routine medical examinations by even non-experts to assess and predict vascular health…
Read More » -
Glenmark launches cardiovascular drugs Sacubitril + Valsartan in India
The launch of Sacubitril + Valsartan has been launched under the brand name Sacu V Glenmark Pharmaceuticals, an innovation‐driven, global…
Read More » -
AstraZeneca’s Dapagliflozin reduces risk of cardiovascular death in DELIVER Phase III trial
Data extend the clinically meaningful benefits of dapagliflozin in patients with heart failure regardless of ejection fraction Detailed results from the…
Read More » -
8th edition of IJCTO concludes in Haryana
The summit demonstrated revolutionary techniques and advanced medical procedures for treating CTO India’s biggest forum for in-depth knowledge on the…
Read More » -
Fish oil do not reduce major cardiac events in high-risk patients: Cleveland study
The study was funded by AstraZeneca Findings from a new Cleveland Clinic study do not support the use of a…
Read More »